title: Behavioural and neurochemical effects of phosphatidylserine in MPTP lesion of the substantia nigra of rats.
abstract: The present study investigated the effects of intranigral MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) infusion on rats treated with phosphatidylserine and evaluated in two memory tasks and on striatal dopamine levels. The results indicated that MPTP produced a significant decrease in the avoidance number in comparison to sham-operated and non-operated rats submitted to a two-way avoidance task. MPTP-lesioned rats exhibited an increase in the latencies to find the platform in cued version of the water maze in comparison to sham-operated and non-operated animals. The tested toxin reduced striatal dopamine levels in comparison to sham-operated and non-operated groups. A final surprising result was that phosphatidylserine was unable to reverse the cognitive deficits produced by MPTP or the reduction of striatal dopamine levels. In conclusion, the data suggest that MPTP is a good model to study the early impairment associated with Parkinson's disease and phosphatidylserine did not improve the memory impairment induced by MPTP.
authors.affiliation: Department of Pharmacology, Federal University of Paraná, Av. Francisco H. dos Santos s/n, 19031 Curitiba, PR, Brazil.
authors.forename: Juliana Cini
authors.initials: JC
authors.lastname: Perry
authors.forename: Claudio
authors.initials: C
authors.lastname: Da Cunha
authors.forename: Janete
authors.initials: J
authors.lastname: Anselmo-Franci
authors.forename: Roberto
authors.initials: R
authors.lastname: Andreatini
authors.forename: Edmar
authors.initials: E
authors.lastname: Miyoshi
authors.forename: Sergio
authors.initials: S
authors.lastname: Tufik
authors.forename: Maria A B F
authors.initials: MA
authors.lastname: Vital
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects* / Q000502:physiology; D001522:Behavior, Animal / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D007274:Injections, Intraperitoneal; D007276:Injections, Intraventricular; D008297:Male; D018782:Maze Learning / Q000187:drug effects* / Q000502:physiology; D010718:Phosphatidylserines / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D013378:Substantia Nigra / Q000187:drug effects* / Q000378:metabolism
chemical_list: D010718:Phosphatidylserines; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine